Neliva

JNJJohnson & Johnson

HealthcareUpdated 2026-03-11
$242.99-0.30%
Open
$242.87
High
$243.69
Low
$241.36
Volume
6.9M
Market Cap
$585.43B
P/E Ratio
21.84
P/B Ratio
7.18
Enterprise Value
$613.27B

Get AI-Powered Analysis of JNJ

Neliva uses real-time data and AI to provide deep research on Johnson & Johnson — including fundamentals, risk assessment, earnings review, and actionable insights.

Research JNJ with AIDeep Analysis

Free to try — no account required for your first research.

About Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) is a publicly traded company in the Healthcare sector, listed as a component of the S&P 500 index. With a market capitalization of $585.43B, it is one of the significant players in its industry. The stock currently trades at a price-to-earnings ratio of 21.84.

Investors and analysts track JNJ for its performance within the Healthcare sector. Using Neliva's AI-powered research tools, you can get comprehensive analysis including real-time pricing, fundamental analysis, technical indicators, news sentiment, and risk assessment — all in seconds.

Frequently Asked Questions

What is the current price of JNJ?
As of 2026-03-11, JNJ is trading at $242.99 (-0.30% today). Range: $241.36 — $243.69.
What is the P/E ratio of JNJ?
JNJ has a P/E ratio of 21.84, helping assess valuation relative to earnings.
Is JNJ a good stock to buy?
Whether JNJ is a good investment depends on your goals and risk tolerance. Neliva’s AI provides comprehensive analysis including valuation, growth, risk factors, and analyst consensus.
What sector is JNJ in?
Johnson & Johnson (JNJ) is in the Healthcare sector of the S&P 500.

Related Healthcare Stocks

LLYEli Lilly and CompanyUNHUnitedHealth Group Inc.ABBVAbbVie Inc.MRKMerck & Co. Inc.TMOThermo Fisher Scientific Inc.ABTAbbott LaboratoriesISRGIntuitive Surgical Inc.PFEPfizer Inc.

Research any stock with AI

Get real-time data, fundamental analysis, risk assessment, and actionable insights — powered by AI.

Get started free